Holocene Advisors, LP Gilead Sciences, Inc. Call Options Transaction History

Holocene Advisors, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $91.4 Million - $99.9 Million	-1,440,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $28.8 Million - $32.9 Million	480,000 Added 50.0%	1,440,000 $93.1 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $54.4 Million - $62 Million	960,000 New	960,000 $55.9 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.